Search research articles
Contact Us
Filters
Showing results (201-210 of 254) with videos related to
Page
of 26
Sort By:
International Journal of Molecular Sciences
|
December 11, 2022
Using Genomic Variation to Distinguish Ovarian High-Grade Serous Carcinoma from Benign Fallopian Tubes
Jesus Gonzalez-Bosquet, Nicholas D Cardillo, Henry D Reyes, et al.
Cancers
|
July 27, 2022
Integrated Clinical and Genomic Models to Predict Optimal Cytoreduction in High-Grade Serous Ovarian Cancer
Nicholas Cardillo, Eric J Devor, Silvana Pedra Nobre, et al.
Medicine
|
October 3, 2014
Oncocytoma-like renal tumor with transformation toward high-grade oncocytic carcinoma: a unique case with morphologic, immunohistochemical, and genomic characterization
Sahussapont J Sirintrapun, Kim R Geisinger, Adela Cimic, et al.
Nature Immunology
|
December 17, 2009
CXCR4 acts as a costimulator during thymic beta-selection
Paul C Trampont, Annie-Carole Tosello-Trampont, Yuelei Shen, et al.
DNA Repair
|
November 22, 2019
Deletion of the SAPS1 subunit of protein phosphatase 6 in mice increases radiosensitivity and impairs the cellular DNA damage response
Jaroslaw Dziegielewski, Magdalena A Bońkowska, Ewa A Poniecka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2005
Preoperative serum tissue factor levels are an independent prognostic factor in patients with ovarian carcinoma
Liz Y Han, Charles N Landen, Aparna A Kamat, et al.
Cancer Research
|
May 15, 1988
No involvement of bovine leukemia virus in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma
A P Bender, L L Robison, S V Kashmiri, et al.
Leukemia
|
October 1, 2011
c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells
T Waldron, M De Dominici, A R Soliera, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 12, 2013
Helix-loop-helix factor inhibitor of differentiation 3 regulates interleukin-5 expression and B-1a B cell proliferation
Heather M Perry, Stephanie N Oldham, Shawn P Fahl, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 17, 2015
A phase I-II evaluation of veliparib (NSC #737664), topotecan, and filgrastim or pegfilgrastim in the treatment of persistent or recurrent carcinoma of the uterine cervix: an NRG Oncology/Gynecologic Oncology Group study
Charles Kunos, Wei Deng, Dawn Dawson, et al.
Page
of 26
Search research articles
Search
Showing results (201-210 of 254) with videos related to
Sort By:
Page
of 26
International Journal of Molecular Sciences
|
December 11, 2022
Using Genomic Variation to Distinguish Ovarian High-Grade Serous Carcinoma from Benign Fallopian Tubes
Jesus Gonzalez-Bosquet, Nicholas D Cardillo, Henry D Reyes, et al.
Cancers
|
July 27, 2022
Integrated Clinical and Genomic Models to Predict Optimal Cytoreduction in High-Grade Serous Ovarian Cancer
Nicholas Cardillo, Eric J Devor, Silvana Pedra Nobre, et al.
Medicine
|
October 3, 2014
Oncocytoma-like renal tumor with transformation toward high-grade oncocytic carcinoma: a unique case with morphologic, immunohistochemical, and genomic characterization
Sahussapont J Sirintrapun, Kim R Geisinger, Adela Cimic, et al.
Nature Immunology
|
December 17, 2009
CXCR4 acts as a costimulator during thymic beta-selection
Paul C Trampont, Annie-Carole Tosello-Trampont, Yuelei Shen, et al.
DNA Repair
|
November 22, 2019
Deletion of the SAPS1 subunit of protein phosphatase 6 in mice increases radiosensitivity and impairs the cellular DNA damage response
Jaroslaw Dziegielewski, Magdalena A Bońkowska, Ewa A Poniecka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 29, 2005
Preoperative serum tissue factor levels are an independent prognostic factor in patients with ovarian carcinoma
Liz Y Han, Charles N Landen, Aparna A Kamat, et al.
Cancer Research
|
May 15, 1988
No involvement of bovine leukemia virus in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma
A P Bender, L L Robison, S V Kashmiri, et al.
Leukemia
|
October 1, 2011
c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells
T Waldron, M De Dominici, A R Soliera, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 12, 2013
Helix-loop-helix factor inhibitor of differentiation 3 regulates interleukin-5 expression and B-1a B cell proliferation
Heather M Perry, Stephanie N Oldham, Shawn P Fahl, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 17, 2015
A phase I-II evaluation of veliparib (NSC #737664), topotecan, and filgrastim or pegfilgrastim in the treatment of persistent or recurrent carcinoma of the uterine cervix: an NRG Oncology/Gynecologic Oncology Group study
Charles Kunos, Wei Deng, Dawn Dawson, et al.
Page
of 26